Although FGF21 has several beneficial effects for glucose and lipid metabolism [78], circulating FGF21 levels are paradoxically increased in humans with obesity, metabolic syndrome [79,80], and NAFLD [81,82,83]. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.